These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15616151)

  • 1. The binding of drugs to hepatocytes and its relationship to physicochemical properties.
    Austin RP; Barton P; Mohmed S; Riley RJ
    Drug Metab Dispos; 2005 Mar; 33(3):419-25. PubMed ID: 15616151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance.
    Griffin SJ; Houston JB
    Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
    Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
    Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds.
    Sohlenius-Sternbeck AK; Afzelius L; Prusis P; Neelissen J; Hoogstraate J; Johansson J; Floby E; Bengtsson A; Gissberg O; Sternbeck J; Petersson C
    Xenobiotica; 2010 Sep; 40(9):637-49. PubMed ID: 20624033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte composition-based model as a mechanistic tool for predicting the cell suspension: aqueous phase partition coefficient of drugs in in vitro metabolic studies.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Aug; 102(8):2806-18. PubMed ID: 23670739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.
    Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I
    Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.
    Austin RP; Barton P; Cockroft SL; Wenlock MC; Riley RJ
    Drug Metab Dispos; 2002 Dec; 30(12):1497-503. PubMed ID: 12433825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
    Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
    Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2007 Aug; 35(8):1325-32. PubMed ID: 17470525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data.
    Kilford PJ; Gertz M; Houston JB; Galetin A
    Drug Metab Dispos; 2008 Jul; 36(7):1194-7. PubMed ID: 18411401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modelling of liver regeneration after intoxication with CCl(4).
    Höhme S; Hengstler JG; Brulport M; Schäfer M; Bauer A; Gebhardt R; Drasdo D
    Chem Biol Interact; 2007 May; 168(1):74-93. PubMed ID: 17442287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
    Paine SW; Parker AJ; Gardiner P; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Jul; 36(7):1365-74. PubMed ID: 18426955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of sandwich-cultured rat hepatocytes to determine the intrinsic clearance of compounds with different extraction ratios: 7-ethoxycoumarin and warfarin.
    Treijtel N; van Helvoort H; Barendregt A; Blaauboer BJ; van Eijkeren JC
    Drug Metab Dispos; 2005 Sep; 33(9):1325-32. PubMed ID: 15951450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding.
    Nakayama S; Atsumi R; Takakusa H; Kobayashi Y; Kurihara A; Nagai Y; Nakai D; Okazaki O
    Drug Metab Dispos; 2009 Sep; 37(9):1970-7. PubMed ID: 19487250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.